AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35486088 — intervention group
Group type: COMPARATOR
Intervention: Cytotec (200 μg) (reference product)
Number of subjects: 48
Study 34347008 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week moderate-intensity aerobic exercise training program (exercise group)
Number of subjects: 60
Study 34596484 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg OD
Number of subjects: 150
Study 34596484 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin 5 mg OD
Number of subjects: 150
Study 34596484 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg OD
Number of subjects: 150
Study 34772982 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES (Neuromuscular Electrical Stimulation) applied bilaterally at thigh and calves for 40 min during each hemodialysis session, three times a week for 1 month
Number of subjects: 21
Study 34772982 — intervention group
Group type: COMPARATOR
Intervention: Control group (no NMES)
Number of subjects: 21
Study 36110857 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy (ART) during primary HIV infection (PHI)
Number of subjects: 51
Study 34375514 — intervention group
Group type: EXPERIMENTAL
Intervention: L. edodes bars (shiitake bars)
Number of subjects: 68
Study 34375514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 36889453 — intervention group
Group type: EXPERIMENTAL
Intervention: Symptom Care at Home (SCH) intervention (n = 144)
Number of subjects: 298
Study 36889453 — intervention group
Group type: COMPARATOR
Intervention: Usual hospice care (UC) (n = 154)
Number of subjects: 298
Study 32949011 — intervention group
Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 live cells (1 × 10^10 cells/day for 12 weeks)
Number of subjects: 90
Study 32949011 — intervention group
Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 dead cells (1 × 10^10 cells/day for 12 weeks)
Number of subjects: 90
Study 32949011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 32949011 — intervention group
Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 live cells
Number of subjects: 90
Study 32949011 — intervention group
Group type: EXPERIMENTAL
Intervention: L. sakei proBio65 dead cells
Number of subjects: 90
Study 33172525 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-education and infographic material, plus 45 text messages via SMS.
Number of subjects: 47
Study 33172525 — intervention group
Group type: COMPARATOR
Intervention: Control group received self-education after the intervention at 3 months.
Number of subjects: 47
Study 35961661 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery rotation
Number of subjects: 115
Study 35961661 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural rotation (emergency medicine, obstetrics and gynecology)
Number of subjects: 115
Study 35961661 — intervention group
Group type: COMPARATOR
Intervention: No procedural rotation
Number of subjects: 115
Study 35961661 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in surgical discipline
Number of subjects: 115
Study 33657295 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus Cabozantinib
Number of subjects: 651
Study 33657295 — intervention group
Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 651
Study 33168406 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 100
Study 33168406 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 100
Study 35209911 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT/MICT
Number of subjects: 73
Study 35209911 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 73
Study 33071178 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic bariatric surgery (MBS)
Number of subjects: 93
Study 33071178 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy (metformin alone or in combination with rosiglitazone or intensive lifestyle intervention)
Number of subjects: 93
Study 34190967 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 3377
Study 34190967 — intervention group
Group type: COMPARATOR
Intervention: Prasugrel
Number of subjects: 3377
Study 33741847 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus with reduced Tacrolimus (EVR+rTAC)
Number of subjects: 772
Study 33741847 — intervention group
Group type: COMPARATOR
Intervention: Standard Tacrolimus (sTAC)
Number of subjects: 772
Study 36031464 — intervention group
Group type: EXPERIMENTAL
Intervention: Midcarpal arthroscopy
Number of subjects: 14
Study 36031464 — intervention group
Group type: COMPARATOR
Intervention: Radiocarpal arthroscopy
Number of subjects: 14
Study 33754155 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted contouring
Number of subjects: 9
Study 33754155 — intervention group
Group type: COMPARATOR
Intervention: Unassisted contouring
Number of subjects: 9
Study 33421652 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-motion video demonstration
Number of subjects: 51
Study 33421652 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time video demonstration
Number of subjects: 51
Study 33421652 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of slow-motion and real-time video demonstration
Number of subjects: 51
Study 33421652 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 51
Study 32969161 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum-assisted excisional biopsy (VAEB)
Number of subjects: 299
Study 32969161 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-surgical-excisional biopsy
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of papillary lesion with atypia
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of flat epithelial atypia
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of atypical ductal hyperplasia
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of lobular carcinoma in situ (LCIS)/atypical lobular hyperplasia with calcification
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of papillary lesion without atypia
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of radial scar
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of classical LCIS without calcification
Number of subjects: 299
Study 32969161 — intervention group
Group type: COMPARATOR
Intervention: Pre-operative diagnosis of mucocoele-like lesion
Number of subjects: 299
Study 35292978 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (4 physical education lessons per week)
Number of subjects: 93
Study 35292978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively demanding exercise intervention (4 physical education lessons per week)
Number of subjects: 93
Study 35292978 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular physical education program of 2 lessons per week)
Number of subjects: 93
Study 33846075 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for PAD
Number of subjects: 0
Study 33846075 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose rivaroxaban
Number of subjects: 0
Study 33846075 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening for PAD (5 year follow up)
Number of subjects: 0
Study 32100628 — intervention group
Group type: EXPERIMENTAL
Intervention: fast‐eccentric BP
Number of subjects: 30
Study 32100628 — intervention group
Group type: EXPERIMENTAL
Intervention: concentric‐only BP
Number of subjects: 30
Study 32100628 — intervention group
Group type: EXPERIMENTAL
Intervention: controlled‐eccentric BP
Number of subjects: 30
Study 32100628 — intervention group
Group type: EXPERIMENTAL
Intervention: experienced participants
Number of subjects: 30
Study 32100628 — intervention group
Group type: EXPERIMENTAL
Intervention: non‐experienced participants
Number of subjects: 30
Study 35275541 — intervention group
Group type: EXPERIMENTAL
Intervention: Kundalini Yoga and Kirtan Kriya (KY+KK) for 12 weeks
Number of subjects: 22
Study 35275541 — intervention group
Group type: COMPARATOR
Intervention: Memory Enhancement Training (MET)
Number of subjects: 22
Study 34106027 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 92
Study 34106027 — intervention group
Group type: COMPARATOR
Intervention: Mind-Body Breathing (MBB)
Number of subjects: 92
Study 36129996 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine U-100
Number of subjects: 5047
Study 36129996 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 5047
Study 36129996 — intervention group
Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 5047
Study 36129996 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin
Number of subjects: 5047
Study 36129996 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 5047
Study 33906908 — intervention group
Group type: EXPERIMENTAL
Intervention: Apabetalone
Number of subjects: 2425
Study 33906908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2425
Study 33906908 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-CKD group
Number of subjects: 2425
Study 32896014 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-centred self-administered acupressure intervention
Number of subjects: 30
Study 32896014 — intervention group
Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 30
Study 34453640 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan‐alone (irinotecan; 150 mg/m2, day 1, q14 days)
Number of subjects: 127
Study 34453640 — intervention group
Group type: EXPERIMENTAL
Intervention: paclitaxel‐alone (paclitaxel; 80 mg/m2, days 1, 8, 15, q28 days)
Number of subjects: 127
Study 34453640 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus irinotecan (irinotecan; 80 mg/m2, days 1, 15, S‐1; 80 mg/m2, days 1-21, q35 days)
Number of subjects: 127
Study 34453640 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 plus paclitaxel (paclitaxel; 50 mg/m2, day 1, 8, S‐1; 80 mg/m2, days 1-14, q21 days)
Number of subjects: 127
Study 35257740 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized poractant alfa 200 mg/kg
Number of subjects: 129
Study 35257740 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulized poractant alfa 400 mg/kg
Number of subjects: 129
Study 35257740 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure
Number of subjects: 129
Study 32366232 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care training (4 sessions, 45 min each)
Number of subjects: 40
Study 35896506 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based COVID-19 risk score displayed to clinicians
Number of subjects: 1010
Study 35896506 — intervention group
Group type: COMPARATOR
Intervention: Control group (no risk score displayed)
Number of subjects: 1010
Study 34036363 — intervention group
Group type: EXPERIMENTAL
Intervention: Sweetened SQ-LNS
Number of subjects: 0
Study 34036363 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsweetened SQ-LNS
Number of subjects: 0
Study 36345917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of photobiomodulation therapy (PBMT) and pulsed electromagnetic field therapy (PEMF)
Number of subjects: 80
Study 36345917 — intervention group
Group type: COMPARATOR
Intervention: Sham device (control group)
Number of subjects: 80
Study 36345917 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PBMT and PEMF
Number of subjects: 80
Study 33971059 — intervention group
Group type: EXPERIMENTAL
Intervention: mMRC dyspnoea scale
Number of subjects: 10072
Study 33971059 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroQol visual analog scale
Number of subjects: 10072
Study 33971059 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyspnoea‐12 score
Number of subjects: 10072
Study 33971059 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐item Patient Health Questionnaire (PHQ‐4)
Number of subjects: 10072
Study 32988520 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS at 13 weeks
Number of subjects: 360
Study 32988520 — intervention group
Group type: COMPARATOR
Intervention: FRS at 13 weeks
Number of subjects: 360
Study 32988520 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS at 8 weeks
Number of subjects: 360
Study 33583447 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized advance care planning (ACP) intervention
Number of subjects: 0
Study 33583447 — intervention group
Group type: EXPERIMENTAL
Intervention: Workshop sessions
Number of subjects: 0
Study 33583447 — intervention group
Group type: EXPERIMENTAL
Intervention: Theme 2 subthemes
Number of subjects: 0
Study 34625784 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-induction WT1 MRD level
Number of subjects: 314
Study 34625784 — intervention group
Group type: EXPERIMENTAL
Intervention: MRDhigh vs MRDlow
Number of subjects: 314
Study 34625784 — intervention group
Group type: EXPERIMENTAL
Intervention: MRD response
Number of subjects: 314
Study 35351779 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication review with shared decision-making (SDM)
Number of subjects: 48
Study 32554543 — intervention group
Group type: EXPERIMENTAL
Intervention: Level 3 barrier protection personal protective equipment (L3PPE)
Number of subjects: 129
Study 34856573 — intervention group
Group type: EXPERIMENTAL
Intervention: Anchor-based device
Number of subjects: 47
Study 34856573 — intervention group
Group type: COMPARATOR
Intervention: Suture-capturing device
Number of subjects: 47
Study 34856573 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 34193110 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care in pediatricians’ practices (intervention group A)
Number of subjects: 0
Study 34193110 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interdisciplinary multimodal intervention at social pediatric centers (intervention group B)
Number of subjects: 0
Study 36100282 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant external beam radiotherapy±brachytherapy ± concomitant chemotherapy
Number of subjects: 514
Study 36100282 — intervention group
Group type: COMPARATOR
Intervention: No additional treatment after radical surgery
Number of subjects: 514
Study 32932273 — intervention group
Group type: EXPERIMENTAL
Intervention: Shave excision
Number of subjects: 45
Study 32932273 — intervention group
Group type: COMPARATOR
Intervention: Elliptical excision
Number of subjects: 45
Study 32319175 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% topical sucralfate ointment
Number of subjects: 40
Study 32319175 — intervention group
Group type: COMPARATOR
Intervention: Vaseline (placebo)
Number of subjects: 40
Study 36066979 — intervention group
Group type: EXPERIMENTAL
Intervention: Cartilage conduction hearing device (CCD)
Number of subjects: 16
Study 36066979 — intervention group
Group type: COMPARATOR
Intervention: Bone conduction devices (BCDs)
Number of subjects: 16
Study 33158949 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 3577
Study 33919799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental implant coverage limited to one tooth per individual
Number of subjects: 30
Study 33919799 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental implant coverage for front teeth
Number of subjects: 30
Study 33919799 — intervention group
Group type: EXPERIMENTAL
Intervention: Government decision to offer coverage for up to two teeth
Number of subjects: 30
Study 35538630 — intervention group
Group type: EXPERIMENTAL
Intervention: Nigella sativa oil supplements (2000mg/day)
Number of subjects: 46
Study 33949055 — intervention group
Group type: EXPERIMENTAL
Intervention: PTFE mesh (ORIHIME™)
Number of subjects: 28
Study 33949055 — intervention group
Group type: COMPARATOR
Intervention: PP mesh
Number of subjects: 28
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Health literacy mean score (13.3±3.6)
Number of subjects: 417
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of Pap smear
Number of subjects: 417
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of cervical cancer
Number of subjects: 417
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness of Pap smear
Number of subjects: 417
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude towards Pap smear
Number of subjects: 417
Study 32711428 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge and attitude towards Cervical Cancer and Pap Smear Questionnaire
Number of subjects: 417
Study 33988236 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferric maltol 30 mg twice daily
Number of subjects: 250
Study 33988236 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ferric carboxymaltose
Number of subjects: 250
Study 33965506 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infected group at 33°C (T6)
Number of subjects: 4
Study 33965506 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infected group at 28°C (T5)
Number of subjects: 4
Study 33965506 — intervention group
Group type: COMPARATOR
Intervention: Control group at 23°C (T1)
Number of subjects: 4
Study 33965506 — intervention group
Group type: COMPARATOR
Intervention: Control group at 28°C (T3)
Number of subjects: 4
Study 33965506 — intervention group
Group type: COMPARATOR
Intervention: Control group at 33°C (T5)
Number of subjects: 4
Study 33965506 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-infected group at 28°C (T4)
Number of subjects: 4
Study 33031340 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral intervertebral foramen block (IFB)
Number of subjects: 100
Study 33031340 — intervention group
Group type: COMPARATOR
Intervention: Local infiltration analgesia
Number of subjects: 100
Study 34889465 — intervention group
Group type: EXPERIMENTAL
Intervention: LGB participants
Number of subjects: 39
Study 34889465 — intervention group
Group type: COMPARATOR
Intervention: Heterosexual participants
Number of subjects: 39
Study 33711179 — intervention group
Group type: EXPERIMENTAL
Intervention: Nemolizumab 30 mg
Number of subjects: 0
Study 33711179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35273052 — intervention group
Group type: EXPERIMENTAL
Intervention: MAMS platform trials evaluating medications
Number of subjects: 62
Study 35273052 — intervention group
Group type: COMPARATOR
Intervention: MAMS platform trials with repurposed medications as comparison arms
Number of subjects: 62
Study 34281405 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Empowered UL Repetitive Engagement (SURE): individualized, UL self-exercise and use outside therapy for 6 hours/week for 4 weeks
Number of subjects: 23
Study 34281405 — intervention group
Group type: COMPARATOR
Intervention: Education booklet (Control)
Number of subjects: 23
Study 32423365 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW-administered screening questions
Number of subjects: 596
Study 32423365 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-administered screening questions
Number of subjects: 596
Study 32423365 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of questions concerning fever, pain, and discolored drainage
Number of subjects: 596
Study 32423365 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall percent agreement between CHW and health center diagnoses
Number of subjects: 596
Study 34128426 — intervention group
Group type: EXPERIMENTAL
Intervention: β-glucan (6 g/day)
Number of subjects: 24
Study 34128426 — intervention group
Group type: EXPERIMENTAL
Intervention: inulin (6 g/day)
Number of subjects: 24
Study 34128426 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter intervention
Number of subjects: 1784
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 1784
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone intervention
Number of subjects: 1784
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated motivational interviewing (MI) call
Number of subjects: 1784
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselor-delivered MI call
Number of subjects: 1784
Study 33823295 — intervention group
Group type: COMPARATOR
Intervention: Survey-only control (Step 1)
Number of subjects: 1784
Study 33823295 — intervention group
Group type: COMPARATOR
Intervention: Step 2 control
Number of subjects: 1784
Study 33823295 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined stepped interventions
Number of subjects: 1784
Study 35606137 — intervention group
Group type: EXPERIMENTAL
Intervention: RED-D (Re-Engineered Discharge for Depression) - a 12-week post-discharge telehealth intervention including cognitive behavioral therapy, self-management support, and patient navigation.
Number of subjects: 709
Study 35606137 — intervention group
Group type: COMPARATOR
Intervention: RED-only (standard Re-Engineered Discharge without depression treatment)
Number of subjects: 709
Study 33047372 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine collagen matrix (CM)
Number of subjects: 14
Study 33047372 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial connective tissue graft (SCTG)
Number of subjects: 14
Study 33749913 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA and DHA, 3.36 g daily
Number of subjects: 31
Study 33749913 — intervention group
Group type: COMPARATOR
Intervention: No EPA/DHA (control)
Number of subjects: 31
Study 33066895 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischemic Post-Conditioning (RIPC)
Number of subjects: 48
Study 33066895 — intervention group
Group type: COMPARATOR
Intervention: Control (Sham Procedure)
Number of subjects: 48
Study 36354383 — intervention group
Group type: EXPERIMENTAL
Intervention: Degludec U100
Number of subjects: 239
Study 36354383 — intervention group
Group type: COMPARATOR
Intervention: Glargine U300
Number of subjects: 239
Study 33914190 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of double support time variability
Number of subjects: 351
Study 33914190 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of step length variability
Number of subjects: 351
Study 33914190 — intervention group
Group type: EXPERIMENTAL
Intervention: Grey matter covariance pattern of step width variability
Number of subjects: 351